If you liked this article you might like

Horizon Fails Late-Stage Freidreich's Ataxia Trial
'Mad Money' Lightning Round: Gilead Sciences, Celgene, Express Scripts
Jim Cramer's 'Mad Money' Recap: Investors See Washington Going Pro-Business